Last edition
News about "Tryngolza"
NICE Recommends Tryngolza for Familial Chylomicronaemia Syndrome
National Institute for Health and Care Excellence issues final draft guidance recommending Tryngolza as a treatment option for eligible adults with familial chylomicronaemia syndrome.
Tryngolza | 03/10/2026 | By News Bureau
MHRA Approves Olezarsen (Tryngolza) for Familial Chylomicronemia Syndrome
MHRA approves olezarsen (tryngolza) for adults with Familial Chylomicronemia Syndrome with subcutaneous injection administration.
Tryngolza | 13/04/2026 | By News Bureau | 178
Sobi Advances Tryngolza Expansion with EMA Validation for sHTG
Sobi has announced that the European Medicines Agency (EMA) has validated its application to expand the indication of Tryngolza (olezarsen) for the treatment of adults with severe hypertriglyceridemia (sHTG), defined by triglyceride levels ≥880 mg/dL (≥10 mmol/L).
Tryngolza | 31/03/2026 | By Darshana | 293
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy